September 19, 2024
Headlines

September 2024

eGenesis Secures $191 Million in Series D Funding to Propel Kidney Transplant Innovation

Editor05 mins

eGenesis, a trailblazer in biotechnology with a focus on developing human-compatible engineered organs, has announced the successful completion of a $191 million Series D financing round. This substantial investment will propel the advancement of eGenesis’s lead product candidate, EGEN-2784, through its first-in-human clinical trials for kidney transplants. Additionally, the funds will facilitate the expansion of…

Read More

ArsenalBio Raises $325 Million in Landmark Series C Round to Accelerate Breakthrough Cell Therapies for Solid Tumors

Editor05 mins

Arsenal Biosciences, Inc. (ArsenalBio), a pioneering force in programmable cell therapy, has announced the successful closure of an oversubscribed $325 million Series C financing round. This significant funding boost reflects a growing confidence in ArsenalBio’s innovative approach to advanced CAR T-cell therapies targeting solid tumors. The Series C round attracted a host of new investors,…

Read More

Revefi Secures $20 Million Series A Funding, Unveils Groundbreaking AI Data Engineer

Editor010 mins

Revefi has announced a significant milestone with the completion of a $20 million Series A financing round. The funding, spearheaded by Icon Ventures and supported by Mayfield, GTM Capital, and StepStone Group, will drive the launch of Raden, an innovative AI data engineer poised to transform data management. Raden, the world’s first AI data engineer…

Read More

Trestle Closes $2.3 Million in Pre-Seed Funding to Revolutionize Construction Management

Editor04 mins

Trestle, the pioneering platform for subcontractor and supplier data centralization and performance management in the construction industry, has successfully secured $2.3 million in pre-seed funding. The round was led by Lerer Hippeau, with participation from MetaProp, Laconia Capital, Alumni Ventures, The LegalTech Fund, Redbud VC, and Meridian Ventures. Trestle, founded in 2022, is designed to…

Read More

Create Wellness Secures $5 Million in Series A Funding to Propel Expansion of Creatine-Based Innovations

Editor05 mins

Create Wellness, Inc., a trailblazer in the health and wellness sector, has successfully raised $5 million in Series A funding, spearheaded by Unilever Ventures. This latest investment boosts Create Wellness’ total funding to $7.3 million. The funds will be instrumental in advancing the company’s mission to broaden access to its pioneering creatine-based products. Founded by…

Read More

Viz.ai and ALCMI Forge Strategic Partnership to Advance Lung Cancer Detection

Editor05 mins

Viz.ai, a trailblazer in AI-driven disease detection and intelligent care coordination, has announced a groundbreaking partnership with the Addario Lung Cancer Medical Institute (ALCMI), a leading international consortium of 25 top lung cancer research institutions. This new collaboration aims to revolutionize early lung cancer detection and enhance patient outcomes through advanced clinical workflows and precision…

Read More

Oyster Secures $59M Series D Funding to Revolutionize Global Employment

Editor06 mins

Oyster®, the leading platform for global employment solutions, has successfully closed a $59 million Series D funding round. The financing, spearheaded by Silver Lake Waterman and supported by notable investors including Emergence Capital, Stripes, Georgian, G2 Venture Partners, and Endeavor Catalyst, positions Oyster to further accelerate its expansion and refine its innovative services. With this…

Read More

Monda Secures $5M Seed Funding to Revolutionize Data Monetization and AI Growth

Editor07 mins

In a significant development for the data-as-a-service (DaaS) sector, Monda has successfully closed a $5 million seed funding round. The financing was spearheaded by Senovo and Acrobator Ventures, with notable participation from Techstars. The new capital will be instrumental in accelerating Monda’s expansion into the US market, scaling its partner network, and further advancing its…

Read More

Segmed Secures $10.4 Million Series A Funding, Ushering in New Era for Medical Imaging Innovation

Editor05 mins

In a significant boost to the field of healthcare innovation, Segmed, Inc. has announced the successful completion of its $10.4 million Series A funding round. This latest round, which saw an oversubscription, was spearheaded by iGan Partners and Advocate Health, with notable contributions from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer…

Read More

AcuraStem Lands $4 Million CIRM Grant to Transform ALS and FTD Treatment

Editor04 mins

AcuraStem, a leading biotechnology firm renowned for its patient-centered approach to treating neurodegenerative disorders, has announced a pivotal development in its research efforts. The company has been awarded $4 million in grant funding by the California Institute for Regenerative Medicine (CIRM). This substantial investment will bolster AcuraStem’s innovative work on its targeted therapeutic program focusing…

Read More